KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $119.0 million.

  • Globus Medical's Net Income towards Common Stockholders rose 12950.46% to $119.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $318.6 million, marking a year-over-year increase of 54251.63%. This contributed to the annual value of -$2.3 million for FY2024, which is 10279.19% down from last year.
  • Latest data reveals that Globus Medical reported Net Income towards Common Stockholders of $119.0 million as of Q3 2025, which was up 12950.46% from $202.8 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Net Income towards Common Stockholders ranged from a high of $202.8 million in Q2 2025 and a low of -$78.7 million during Q4 2024
  • In the last 5 years, Globus Medical's Net Income towards Common Stockholders had a median value of $45.3 million in 2021 and averaged $41.3 million.
  • The largest annual percentage gain for Globus Medical's Net Income towards Common Stockholders in the last 5 years was 509398.8% (2024), contrasted with its biggest fall of 19319.33% (2024).
  • Quarter analysis of 5 years shows Globus Medical's Net Income towards Common Stockholders stood at $1.9 million in 2021, then surged by 1610.86% to $32.0 million in 2022, then tumbled by 183.99% to -$26.9 million in 2023, then tumbled by 193.19% to -$78.7 million in 2024, then skyrocketed by 251.09% to $119.0 million in 2025.
  • Its last three reported values are $119.0 million in Q3 2025, $202.8 million for Q2 2025, and $75.5 million during Q1 2025.